Fundraising Fox

Deerfield Management Company2022 Investments

6 investments dated 2022 · listed companies and verified rows first · show all

Acutus Medicalacutusmedical.comJul 2022

HealthtechCarlsbad, US

Christoph Scharf(Director)inRandy Werneth(Executive Officer, Director)Graydon Beatty(Executive Officer)inVince Burgess(Director)John Dahldorf(Executive Officer)

BoardAditya Puri(Director)

Board seatAndrew ElBardissi· per SEC Form D

Co-investorsAdvent Life SciencesOrbiMedGE VenturesIndex Ventures

Appello Pharmaceuticalsappellopharma.comJan 2022SEC filingmedium confidence

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesNashville, US

Dr. Laden(Co-founder)Christopher Rand(Executive Officer)Vaughn Bryson(Director)Jeff P. Conn(Director)

BoardWilliam Slattery(Director)Howie Furst(Director)in

Board seatHoward Furst· per SEC Form D · $13.5M raise · filed Jan 2022

Co-investorsMountain Group CapitalRelevance Ventures

Aurion Biotechaurionbiotech.cominApr 2022SEC filingmedium confidence

Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.

BiotechHealthtechMedical DevicesSeattle, US

DAVID ROSTOV(Executive Officer)GREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)

Board seatAndrew ElBardissi· per SEC Form D · $26.1M raise · filed Apr 2022

Co-investorsVisionary VenturesFlying L Partners

Humanity Health, Inc.Jul 2022SEC filingmedium confidence

New York, US

Kathryne Cooper(Director)Ronald Mitchell(Executive Officer, Director)Jonathan Ramos(Executive Officer)

BoardMichael Farrell(Executive Officer)in

Board seatBharath GanesanJulian Harris· per SEC Form D · $11M raise · filed Jul 2022

InnervaceAug 2022SEC filingmedium confidence

BiotechNew York, US

Nader Halim(Executive Officer, Director)Althea Stillman(Executive Officer, Director)

BoardDavid Greenwald(Director)in

Board seatJonathan Leff· per SEC Form D · $40M raise · filed Aug 2022

Co-investorsBioAdvance

Neochordneochord.comin𝕏Nov 2022SEC filingmedium confidence

NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.

Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US

Todd Berg(Executive Officer, Director)David H. Chung(Executive Officer, Director)Ron Nelson(Executive Officer)

BoardCasey Tansey(Director)Mudit K. Jain(Director)

Board seatAndrew ElBardissi· per SEC Form D · $6M raise · filed Nov 2022

Co-investorsTreo Ventures, LlcUS Venture Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.